MacroGenics
MGNX
#9411
Rank
C$0.18 B
Marketcap
C$2.94
Share price
3.54%
Change (1 day)
47.26%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): C-$0.77

According to MacroGenics's latest financial reports the company's current EPS (TTM) is C-$0.82. In 2025 the company made an earnings per share (EPS) of C-$1.69 a decrease over its 2024 EPS that were of C-$1.53.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.77-54.71%
2025C-$1.6910.28%
2024C-$1.53613.33%
2023C-$0.21-92.31%
2022C-$2.79-42.14%
2021C-$4.8336.44%
2020C-$3.54-21.84%
2019C-$4.53-24.58%
2018C-$6.00675.93%
2017C-$0.77-68.05%
2016C-$2.42168.25%
2015C-$0.90-55%
2014C-$2.013400%
2013C-$0.05730-108.68%
2012C$0.6624.49%
2011C$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02-224.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.25-5,519.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.90-3,149.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$4.44 443.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.47-892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C-$2.25 175.44%๐Ÿ‡บ๐Ÿ‡ธ USA